Pharmacology of Antibacterial Agents (Coursera)

Pharmacology of Antibacterial Agents (Coursera)

The online course “Pharmacology of antibacterial agents” has been designed and developed by the team of authors of Department of General and Clinical Pharmacology, Medical Institute of People’s Friendship University of Russia (RUDN University). The main objective of the course is to provide systemic knowledge on pharmacokinetic and pharmacodynamic parameters of the main groups of antibacterial agents and insight into their proper and safe use.

Class Deals by MOOC List - Click here and see Coursera's Active Discounts, Deals, and Promo Codes.

The course is divided into 11 Modules covering the main questions of rational antibacterials’ use, pharmacodynamics, pharmacokinetics, indications, contraindications, adverse drug reactions of the main classes of natural antibiotic and synthetic agents, and parameters of their safety and use in specific population of patients.
The course is performed with multimedia enriched videos, complementary educational material, interactive links to the actual articles and guidelines according to each module, and online Quizzes.
The course “Pharmacology of antibacterial agents” is intended for students studying Medicine (including next specialties: General Medicine, Pharmacy, Dentistry, Pediatric), post-graduate students studying Clinical Pharmacology and clinicians who want to refresh knowledge on antibacterial agents’ pharmacology. Students of medical universities of 2nd year education and up.

Syllabus

WEEK 1
Introduction to the course of Pharmacology of antibacterial agents. Rational antibiotic therapy
Week 1 is “Introduction to the course of Pharmacology of antibacterial agents. Rational antibiotic therapy”, which is aimed on consideration of the actual problems of antibiotic use.

WEEK 2
Pharmacodynamics of antibacterial drugs
Week 2 is “Pharmacodynamics of antibacterial drugs”, highlighting the main mechanisms of antibacterial action, types of effects, general mechanisms of antibacterial resistance development and strategies to overcome it.

WEEK 3
Pharmacokinetics of antibacterial agents
Week 3 is “Pharmacokinetics of antibacterial agents”, dedicated to next parameters, absorption and bioavailability, distribution, and elimination, as well as to pharmacokinetic drug interactions.

WEEK 4
Beta-lactam antibiotics. Penicillins
Week 4 is “Beta-lactam antibiotics. Penicillins”, it includes the questions of beta-lactams classification with consideration of penicillins pharmacodynamic and pharmacokinetic parameters, indications, contraindications, adverse drug reactions including penicilliun-induced allergy, resistance mechanisms and ways to fight them.

WEEK 5
Beta-lactams. Cephalosporins. Carbapenems. Monobactams
Week 5 is “Beta-lactams. Cephalosporins. Carbapenems. Monobactams”, dedicated to the named groups of beta-lactam antibiotics and the actual parameters of their effective and safe use.

WEEK 6
Pharmacology of natural antibiotics
Week 6 is “Pharmacology of natural antibiotics”, covering the main pharmacologic characteristics and actual problems of effective and safe use of Tetracyclines, Aminoglycosides, Macrolides, Glycopeptides, Streptogramins, Lipopeptides, Lincosamides.

WEEK 7
Pharmacology of antibacterials of synthetic origin
Week 7 is “Pharmacology of antibacterials of synthetic origin”, dedicated to the main parameters of pharmacokinetics and pharmacodynamics, indications, contraindications, adverse drug reactions and safe use of Quinolones/Fluoroquinolones, Phenicols, and Oxazolidinones.

WEEK 8
Pharmacology of antibacterial drugs against Mycobacterium tuberculosis
Week 8 is “Pharmacology of antibacterial drugs against Mycobacterium tuberculosis”, which is aimed on providing information about pharmacologic characteristics of the first line antituberculosis agents and highlining the actual problems of their safe use.

WEEK 9
Antibacterial agents’ safety. Part I
Week 9 is “Antibacterial agents’ safety. Part I”, covering the actual problems of antibiotic-induced cardiotoxicity, nephrotoxicity, adverse drug effect involving skeletal muscles.

WEEK 10
Antibacterial agents’ safety. Part II
Week 10 is “Antibacterial agents’ safety. Part II”, which includes actual questions regarding antibiotic-associated neurotoxicity, gastrotoxicity, and hematotoxicity.

WEEK 11
Antibacterial agents use in special populations
Week 11 is “Antibacterial agents use in special populations”, highlining the main problems of safe and effective antibiotic use in pediatric practice, in elderly and geriatric patients, in hepatic or renal failure.

Go to Class
MOOC List is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Related Courses

Intravenous to Oral Switch: Within Outpatient Parenteral Antibiotic Therapy (IVOST) (FutureLearn) FutureLearn
British Society for Antimicrobial Chemotherapy - BSAC

Intravenous to Oral Switch: Within Outpatient Parenteral Antibiotic Therapy (IVOST) (FutureLearn)

Are you involved in the prescribing/administration of antibiotics? Explore the benefits and barriers of IVOST and COPAT. Discover the principles and practices supporting IVOST and COPAT. The use of intravenous antimicrobials and complex oral antimicrobial regimes within outpatient clinical environments is helping with non-admission to and early discharge from hospital. The course will lead you through the principles underlying these therapies, how to determine their suitability, and key practices for prescribers.

Self Paced
4 Weeks
Antimicrobial Stewardship: Managing Antibiotic Resistance (FutureLearn) FutureLearn
University of Dundee,British Society for Antimicrobial Chemotherapy - BSAC

Antimicrobial Stewardship: Managing Antibiotic Resistance (FutureLearn)

Understand antibiotic resistance, and how antimicrobial stewardship can slow down or reduce it, with this free online course. Antimicrobial stewardship is a fast-growing field that aims to address this issue by managing our use of antibiotics to slow down or reduce the occurrence of antimicrobial resistance. Designed for healthcare professionals, this six-week course will inform you about - and empower you to provide - safe, high-quality antibiotic use.

Self Paced
5-12 Weeks
Introduction to Pharmacokinetics: From ADME to PK/PD (edX) EdX
Davidson College,DavidsonX

Introduction to Pharmacokinetics: From ADME to PK/PD (edX)

A critical aspect of a drug involves how a drug is dosed and circulates throughout the body of a patient. These qualities are aspects of a drug’s pharmacokinetics or PK. Pharmacokinetics encompasses how a drug is absorbed and flows through a patient until it is ultimately eliminated. While pharmacokinetics covers drug behavior in a living organism, PK properties can often be predicted through laboratory tests for a compound’s ADME properties. ADME stands for absorption, distribution, metabolism, and excretion. The PK and ADME properties of potential drug are closely monitored throughout the discovery and early development stages of a drug campaign.

Self Paced
Self-Paced
Farmacovigilancia ocular (Coursera) Coursera
Universidad Nacional Autónoma de México

Farmacovigilancia ocular (Coursera)

En este curso, el participante identificará entre una reacción adversa al medicamento, un evento temporalmente asociado a vacunas y las consecuencias adversas de las tecnologías médicas. Se busca la mejora de la seguridad del paciente al disminuir el riesgo de pérdida de la visión o afecciones oculares secundarias a través de la valoración del caso y la aplicación de técnicas diagnósticas oculares.

Oct 12th 2026
4 Weeks
Precision Medicine (Coursera) Coursera
University of Geneva

Precision Medicine (Coursera)

This course will provide you with the key knowledge and tools to understand the fundamentals and practical implications of precision medicine, its opportunities and challenges. It will address precision-medicine era diagnostics, treatment selection, genetic counseling, public health interventions, and biomedical research. It will also deal with data science and ethical issues. From genomic analysis and genetic counseling to cancer biomarkers, from risk assessment of chronic diseases to the understanding of gene-environment interactions, from pharmacogenomics to multi-omics data integration, experts will walk you through the many aspects of precision medicine, from the bench to the bedside and to population health.

Sep 21st 2026
5-12 Weeks
Preclinical Safety: From In Vitro Assays to Human Dose Predictions (edX) EdX
Davidson College,DavidsonX

Preclinical Safety: From In Vitro Assays to Human Dose Predictions (edX)

Drugs are approved based on their “safety and efficacy”. Determining the safety of a drug occurs through studies that are largely completely separate from efficacy studies. The safety studies fall under the umbrella of preclinical safety. While a drug’s therapeutic benefit is typically narrow and well-defined, the potential safety risks of a compound can be very broad. Preclinical studies therefore search broadly in order to reveal any possible safety issues in a compound. Safety studies ultimately determine dosing limits for clinical trials as well as the final approved drug product.

Self Paced
Self-Paced
Antimicrobial Stewardship for Africa (FutureLearn) FutureLearn
British Society for Antimicrobial Chemotherapy - BSAC,ICAN - Infection Control Africa Network,College of Medicine, University of Lagos

Antimicrobial Stewardship for Africa (FutureLearn)

Improve your knowledge of the spread of antimicrobial resistance in Africa and how to reduce it. Learn how to tackle antimicrobial resistance in Africa. Communicable diseases remain to be a leading cause of death in African countries (WHO). This course will look at the threat of antimicrobial resistance in Africa and how best to tackle it.

Self Paced
3 Weeks
Preventing and Managing Infections in Childcare and Pre-school (FutureLearn) FutureLearn
British Society for Antimicrobial Chemotherapy - BSAC,Public Health England

Preventing and Managing Infections in Childcare and Pre-school (FutureLearn)

Understand how infectious diseases spread and how to protect children from infections. Identify how to prevent the spread of infectious diseases in children. Microbes live everywhere, especially in childcare settings where children play together at close quarters. They come in all shapes and sizes – and not all are harmful. On this course, you’ll discover what germs are and how they spread, looking at simple ways of stopping infections spreading. You’ll learn practical tips on keeping early years settings safe.

Self Paced
2 Weeks
Clinical Pharmacokinetics: Dosing and Monitoring (FutureLearn) FutureLearn
Taipei Medical University

Clinical Pharmacokinetics: Dosing and Monitoring (FutureLearn)

Understanding pharmacokinetics, from basic principles to clinical applications. Explore the key principles of pharmacokinetics and how to apply them. On this course you will learn about the principles of clinical pharmacokinetics, including factors that affect the absorption, distribution, metabolism, excretion, and binding of drugs.

Self Paced
5-12 Weeks
Optimización del uso de antimicrobianos: Gestión de la resistencia a los antimicrobianos (FutureLearn) FutureLearn
University of Dundee,British Society for Antimicrobial Chemotherapy - BSAC

Optimización del uso de antimicrobianos: Gestión de la resistencia a los antimicrobianos (FutureLearn)

Entender la resistencia a los antibióticos, y cómo la administración antimicrobiana puede ralentizar o reducirla, con este curso. Diseñado para los profesionales sanitarios, este curso de seis semanas te informará sobre —y te capacitará para proporcionar— un uso seguro y de alta calidad de los antibióticos.

Self Paced
5-12 Weeks
Pharmacokinetics (Coursera) Coursera
Novartis

Pharmacokinetics (Coursera)

This course begins with a review of routes of administration, ADME (absorption, distribution, metabolism, & excretion), and the use of in vivo drug concentration-time data to determine key pharmacokinetic parameters, like volume of distribution, half-life and clearance.  The course then emphasizes in vitro assays that allow rapid prediction of ADME and PK properties for evaluation of new compounds. 

Sep 21st 2026
3 Weeks